Inside the Challenges of Isotope Production

Description

Undesired contaminates, equipment failure, raw material availability, regulatory issues—these are just a few of the challenges faced by manufacturers of the radioisotopes needed for production and preparation of radiopharmaceuticals. Learn about all of these and more as experts provide an overview of the production options for Lutetium-177 and cyclotron- produced Gallium-68.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Describe and compare direct and indirect production methods of Lutetium-177 and list advantages and disadvantages of both production methods.
  2. Discuss regulation and safety considerations of isotope production.
  3. Explain the cyclotron production process for Gallium-68.
  4. Summarize the advantages and disadvantages of using a cyclotron for the production of Gallium-68.
  5. Compare the quality control testing of cyclotron-produced Gallium-68 to generator-produced Gallium-68.
 

Joint Providership

This activity is approved for Board Certified Nuclear Pharmacist (BCNP) recertification credits.

 
 
Speakers:
Peter
Peter Scott, PhD
Research Associate Professor
University of Michigan
 
Kenneth
Kenneth Brooks, CPA, MBA
Associate Director
MU Research Reactor
 
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Date: 
Saturday, March 23
Time: 
7:00 AM - 9:00 AM
Room: 
Washington State Convention Center - Room 615-617
ACPE Pharmacist: 0202-0000-19-031-L04-P
CEUs Pharmacist: .2
Activity Type:
Knowledge-based